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LowdopamineD2receptor(D2R)levelsinthestriatumareconsistentlyreportedincocaineabusers;inter-individualvariationsin
thedegreeofthedecreasesuggestamodulatingeffectofgeneticmakeuponvulnerabilitytoaddiction.ThePER2(Period2)gene
belongstothe clock genes family ofcircadianregulators; circadian oscillations ofPER2 expressionin the striatumwas modulated
by dopamine through D2Rs. Aberrant periodicity of PER2 contributes to the incidence and severity of various brain disorders,
including drug addiction. Here we report a newly identiﬁed variable number tandem repeat (VNTR) polymorphism in the human
PER2 gene (VNTR in the third intron). We found signiﬁcant differences in the VNTR alleles prevalence across ethnic groups so
that the major allele (4 repeats (4R)) is over-represented in non-African population (4R homozygosity is 88%), but not in African
Americans (homozygosity 51%). We also detected a biased PER2 genotype distribution among healthy controls and cocaine-
addicted individuals. In African Americans, the proportion of 4R/three repeat (3R) carriers in healthy controls is much lower than
that in cocaine abusers (23% vs 39%, P¼0.004), whereas among non-Africans most 3R/4R heterozygotes are healthy controls
(10.5% vs 2.5%, P¼0.04). Analysis of striatal D2R availability measured with positron emission tomography and [
11C]raclopride
revealedhigherlevelsofD2Rincarriersof4R/4Rgenotype(Po0.01).Takentogether,theseresultsprovidepreliminaryevidence
for the role of the PER2 gene in regulating striatal D2R availability in the human brain and in vulnerability for cocaine addiction.
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Introduction
Low striatal dopamine D2 receptor (D2R) levels have consis-
tentlybeen reported incocaine abusers
1–3andanimal models
of addiction.
4,5 In humans, low D2R density has been asso-
ciated with decreased metabolism in the orbital frontal
cortex.
6 It was proposed that the altered dopamine (DA)
signaling may lead to compulsive drug administration and,
subsequently, to cocaine addiction.
6–9 On the other hand,
drugs of abuse, including cocaine, exert their reinforcing
effects by enhancing signaling in the mesolimbic and nigro-
striatal DA pathways (reviewed in ref.10), so that the chronic
cocaine exposure can cause stable changes in gene
transcription, mRNA translation and metabolism,
11 thus
further intensifying D2R loss.
5
Marked differences in individual responses to both acute
and chronic cocaine administration are likely to reﬂect an
impact of individual genomic makeup that is modulated by
environmental factors.
12,13 Drug addiction is highly heritable
(estimated heritability is about 0.72).
14 As a complex non-
Mendelian disorder, it is likely inﬂuenced by many genes;
14
the known candidate genes cannot, however, explain this
level of heritability.
15 Among the most studied candidate
genes for substance-use disorders
14 is the DRD2 gene.
Although the individual differences in the DRD2 expression
are well established,
16 it is not clear as to how the level of
expression is regulated. Many human studies have focused
on a single genetic variant, the DRD2/ANKK1 polymorphism
(reviewed in ref.17), but inconsistency of the results of those
studies
18–20 creates the need to identify new genetic targets
that have regulatory relationships with the DRD2.
Recent results from genetics of gene expression studies
have demonstrated a role of polymorphic regulatory regions
located in trans tothe targetgene.
21 Regulation intrans bythe
clock genes, for example, leads to circadian oscillation of the
expression ofthemajorityofthehumangenes,including brain
genes.
22 Here we developed and tested the hypothesis that
the PER2 (Period 2) clock gene might contribute to the
regulation of D2R expression in the brain and, as such, might
be associated with cocaine addiction, based on the following
lines of evidence: (1) DA release in the striatum is subject to
circadian oscillation;
23 (2) PER2 modulates the reinforcing
effects of cocaine in laboratory animals;
24 and (3) individuals
suffering from substance-use disorders
25,26 have aberrant
patterns of sleep and circadian rhythmicity.
In rats, the expression of clock genes and extracellular DA
levels in the dorsal striatum
27–29 exhibits daily oscillations. As
striatal PER2 ﬂuctuations are DA-sensitive,
27 it is possible
that the periodicity of DA release can mediate or be mediated
by D2R–PER2 regulatory relationships.
Our understanding of the molecular mechanisms of the
circadian clockworks has been largely based on the studies of
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are ubiquitous, unique evolution of human lineage suggests
that human clock genes might have distinct genomic features.
That is, colonizing the world humans experienced highly
diverse effects of new environments, notably, changes in
photoperiodicity and seasonal rhythmicity. Speciﬁc popula-
tions thus had developed unique adaptations to particular
climate zones and environments. Circadian periodicity is
entrained by temperature and day–night cycle; those environ-
mental inputs change in association with latitude, challenging
the clock. It therefore seems likely that positive selection
affected clock genes in modern humans, and, as such, these
genes would have sequence characteristics and genomic
features absent in ancestral lineage. Intra-species clock
variations have distinct geographic pattern of distribution,
30
suggesting that population-speciﬁc polymorphisms can
enable highly adjustable regulation pattern required for
population-speciﬁc adaptations.
The PER2 locus has higher levels of inter-population
genetic differentiation relative to other loci, suggesting a role
for geographically restricted positive selection.
31 Much lower
than expected under a model of neutrality estimate of the
coalescence age of the putatively selected PER2 haplogroup,
and relatively low FST values of the ﬂanking polymorphic sites
in both Africans vs Europeans and Africans vs Asian
comparisons,
31 both indicate that the PER2 locus was
affected by selection after the out-of-Africa expansion.
In humans, single-nucleotide polymorphisms (SNPs) in
the PER2 gene have been associated with abnormal
circadian parameters,
32 chronotypes,
33 depression
34 and
also with enhanced alcohol intake,
35 although no relationship
with cocaine dependence was found in a case–control study
that focused on several PER2 SNPs.
36
The mutagenic potential of repeat regions is higher than
that of single point mutations,
37 making them more favorable
for generating potentially ‘adaptable’ genetic substrates.
Indeed, a correlation between a PER2 repeat polymorphism
(microsatellite) and latitude was reported in Drosophila
melanogaster,
38 where clinal distribution pattern of micro-
satellite alleles suggested that the latitudinal structure of this
polymorphism may facilitate ﬁne tuning of circadian oscilla-
tion. We postulated that putatively polymorphic repeat
variation in the human PER2 might enable environmentally
inﬂuenced transcriptional regulation in a population-speciﬁc
manner. Here, we report evidence supporting this hypothesis.
We identiﬁed and characterized new variable number
tandem repeat (VNTR) polymorphism in intron 3 of the
PER2 by comparing the prevalence of the VNTR alleles
among African Americans and non-Africans, and among
healthy controls and cocaine abusers. We also assessed the
effect of this polymorphism on striatal D2R expression using
brain imaging data (obtained with positron emission tomo-
graphy (PET) using the D2R–radioligand [
11C]raclopride).
We found an association between the PER2 genotype and
striatal D2R availability, as well as signiﬁcant differences in
VNTR allele frequencies between cocaine abusers and
healthy controls that, in combination, point out that this
genetic variation can contribute to vulnerability for cocaine
addiction and other disorders of behavioral control that are
associated with low striatal D2R levels (such as, obesity).
39
Multi-allelic genetic markers, such as the PER2 intron 3
VNTR, provide information on the evolutionary history of
populations
40,41 and help to identify the loci targeted by
selection.
42 Previously, signals for population-speciﬁc selec-
tion acting on the PER2 gene were detected using a SNP-
based analysis.
31 Our VNTR-based analyses revealed signi-
ﬁcantlydifferentpatternsofPER2allelesandgenotypesacross
ethnic groups; this ﬁnding, along with population-speciﬁc SNPs
and FST values and local recombination rate, points to the
involvement of positive selection in the evolution of this gene.
Materials and methods
Bioinformatic analyses. We used SERV server (http:www.
igs.cnrs-mrs.fr/SERV/) to estimate repeats variability and
suitability for genotyping. For assessment of the signs of
selection, we used the Human Genome Diversity Panel
browser (http://hgdp.uchicago.edu/cgi-bin/gbrowse/HGDP/),
which is based on the data from the Human Genome
Diversity Panel CEPH and the Phase II HapMap.
43 Population-
speciﬁc SNPs were obtained using Genome Variation Server
(http://gvs.gs.washington.edu/GVS/).
Participants. A population sample included 509 unrelated
individuals originally recruited for different imaging studies
who also agreed to participate in a genetic study approved by
the IRB of Stony Brook University. Written informed consent
was obtained from each subject after the study had been fully
explained to them. All demographic data and clinical
measures were acquired via the original imaging study.
Race and ethnicity was deﬁned by self-assignment.
DNA extraction and genotyping. DNA was extracted from
the blood cells using the PAXgene kit (Qiagen, Germantown,
MD, USA). The following primers (forward: 50-TTGGGTTA
GAGCGGTGA-30 and reverse: 50-CTAGGTGTCCTTTCC
TGA-30) were used to amplify the region encompassing VNTR
(4chr2: 239184578–239185009). The size of the polymerase
chain reaction (PCR) products was established by QIAxcel
system of a multi-capillary electrophoresis. Individual genotype
assignment was carried out based on the PCR results,
wherein the alleles were categorized as four repeat ‘4R’
(333bp product), three repeat ‘3R’ (277bp) and two repeat
‘2R’ (212bp).
PET imaging data. The [
11C]raclopride values associated
with the genetic samples were retrieved from the imaging
data set of the BNL Brain Imaging Center for studies
performed over the period 2006–2010. All PET scans used
in this study were performed on a Siemens, HRþ scanner.
The procedures for subjects positioning and the scanning
protocols were described previously
1,2 and the imaging
results have been reported.
2,6 In this study, we used
regional Bmax/KD values calculated for three regions of
interest: caudate, putamen and ventral striatum.
Statistical analysis. Because the genetic model for this
locus is unknown, we ﬁrst used four-genotype classiﬁcation,
where the carriers of each observed genotype formed a
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three common genotypes: ‘4R/4R’, ‘4R/3R’ and ‘3R/3R’
and ‘rare’, which comprised of carriers of 2R allele.
PER2 genotypes were evaluated with regard to the Hardy–
Weinberg equilibrium (HWE) using the OEGE software
http://www.oege.org/software/hwe-mr-calc.shtml
44 and popgen
genetic applet http://www.husdyr.kvl.dk/htm/kc/popgen/genetik/
applets/kitest.htm.
All individuals participating in the imaging study were
African Americans; therefore, in exploratory analyses of
imaging data, we tested potential confounding effects of sex
and age. Sex differences in striatal D2R binding were not
signiﬁcant (t-test), but age negatively correlated with D2R
availability at Po0.01 level (t-test, two-tailed) as has been
reported previously.
45 Fitting a general linear model showed
low importance of the gender with respect to the D2R levels
(P¼0.342) and, as expected,
45 a strong effect of age
(Po0.001); hence, age was included in a model. Analysis of
the relationships between the D2R brain availability and the
PER2 genotypes was performed with analysis of covariance
(general linear model), where a regional Bmax/KD value was
treated as dependent variable, PER2 genotype as between-
subjects factor and age was introduced as a covariate.
Because the regions of interest imaging data did not meet
the condition of sphericity (Maunchy’s test statistic P¼0.008,
Greenhouse–Geisser¼0.815), we analyzed the three brain
regions independently.
All effects are reported at three conditions: the F value (F),
the degrees of freedom (d.f.) and the Sig. (P-value). Partial
eta-squared (ZP
2) is the measure of effect size. Effects were
reported as statistically signiﬁcant at Po0.05.
The statistical tests were performed using the SPSS
software (version 11.5).
Results
Computational analysis of the PER2 locus: identiﬁcation
and characterization of a new VNTR polymorphism.
While examining the PER2 sequence, we noticed what
appeared to be a 62-bp tandem repeat in intron 3
immediately preceding exon 4 (chr2q37.3; hg19—chr2:
239184615–239184862; Figure 1a). PCR ampliﬁcation of
genomic DNA from several humans with primers ﬂanking this
region yielded polymorphic fragments differing by
approximately 62 bases. The most frequent allele (432bp)
has a length corresponding to the reference genome
sequence, that is, it has 4R. In addition, we also observed
alleles with 3R and 2R, which occur in homozygous and
heterozygous states. Conservation tracks show that other
species, including primates, lack the repeat’s consensus,
indicating that this allele is derived (Figure 1b).
Distribution of VNTR allele and genotype frequencies
in populations. Next, we tested the PER2 intron 3 VNTR
allele frequencies in the population sample (N¼509).
Table 1 shows the demographic characteristics of the
sample. In our population, the most frequent allele has 4Rs
(N¼820), followed by 3R (N¼156) and 2R (N¼42) alleles.
We noticed a close similarity in genotype distribution patterns
in Hispanic and Caucasian subpopulations; subsequently,
we divided the sample on African Americans (N¼286) and
non-Africans (N¼223) subsamples. Because of the low
frequency of the 2R allele, the individuals who carry 2R
allele(s) were assigned to the genotype group ‘rare’.
The frequencies of the VNTR-based genotypes showed
statistically signiﬁcantdifferencesbetweenAfricanAmericans
and non-Africans (w
2¼81.1, d.f.¼3, Po0.001). Minor allele
frequency (3R) was 0.22 in the African Americans and only
0.056 in non-Africans. Table 2 shows the observed genotype
count and population-speciﬁc genotype frequencies in
percentiles.
The PER2 genotype frequencies deviated from the values
expected under HWE; we detected this deviation both by
analyzingthesampleasawholeandtestingAfrican-American
and non-African subsamples separately. The results of HWE
calculations (w
2 test) using the OEGE software (bi-allelic
markers) and popgen genetic applet (multi-allelic markers)
are shown in Table 3a and b, respectively.
A deﬁcit of heterozygotes in relation to HWE, as it is
observed in our sample, points to non-random mating or
population stratiﬁcation rather than to genotyping errors;
46
nonetheless, we validated the PCR results by testing more
than 300 samples as duplicates and triplicates, as well as
tested half of the samples (about 250) using a different PCR
system and protocols (not shown). Test–retest procedure
conﬁrmed genotyping assignment with a 100% accuracy. A
large number of cocaine abusers in our sample (see below)
suggested a possibility that bias distribution of the PER2
genotypeswasduetothe disease.WhenwetestedHWE only
in healthy control groups within the ethnic subsamples, we
found a good agreement between the observed and the
expected frequencies (African Americans: w
2¼1.57, P40.1;
non-Africans: w
2¼2.79, P40.05).
Unequal distribution of VNTR genotypes in healthy
controls and cocaine users. We next examined a
potential effect of the VNTR polymorphism on the risk for
cocaine addiction by comparing PER2 genotype frequencies
in healthy controls and in cocaine abusers. Considering
the differences in genotype distribution patterns, we ran
separate analyses for the ethnic subsamples. Table 4 shows
the absolute numbers (actual count) of the genotypes
in the groups of healthy controls and cocaine abusers and
Figure 2 illustrates the differences in the patterns of genotype
distribution between the disease groups in two populations.
The relationship between the PER2 genotype (four geno-
types classiﬁcation) and diagnosis was statistically signiﬁcant
in both subsamples (African Americans: w
2¼8.63, d.f.¼3,
P¼0.035; non-Africans: w
2¼8.25, d.f.¼3, P¼0.041).
As clearly seen from Figure 2, in African Americans the
proportion of 4R/3R carriers in cocaine abusers is much
higher than that in healthy controls (39% vs 23%). This
difference is statistically signiﬁcant: w
2¼8.2, d.f.¼1,
P¼0.004. It appears that the 4R/3R genotype increases a
risk for cocaine addiction, but only in the African-American
population. In non-Africans, in contrast, 10.1% of healthy
controls but only 2.5% of cocaine abusers carry 4R/3R
genotype; thus, 4R/3R heterozygotes seem to be protected.
Because most non-African individuals carry two major (4R)
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we applied a binomial analysis comparing the 4R/4R homo-
zygotes with the carriers of at least one minor allele
(two genotypes classiﬁcation). Under this partitioning, the
interaction between the PER2 genotype and diagnosis
(controls vs cocaine abusers) for the whole sample was
Figure 1 Location and genomic features of the human PER2 (Period 2) gene. (a, Upper panel) The locus of the chromosome 2 (q37.3) corresponding to the PER2 gene
(red box). A snapshot of the PER2 locus (UCSC Genome Browser, hg19) illustrates its major genomic features, including high recombination rate (dark gray bar on the top),
GC enrichment (GC % shown in full), multiple single-nucleotide polymorphisms (SNPs) and tandem repeats. Polymorphic variable number tandem repeat (VNTR) (red circle)
resides immediately upstream of intron 3 (green arrow). (b) The light blue arrowheads indicate positions of the primers used to amplify VNTR region. As evident from the
conservationtracks,theconsensusofthepolymorphictandemrepeat(blackbaratthebottom)islackingintheotherspecies,includingprimates(yellowarrowsarepointingto
boundaries of a gap in the Rhesus macaque sequence).
Table 1 Demographic characteristics of the sample
N Male Female Healthy controls Cocaine abusers
African Americans 286 208 (72.7%) 76 (26.6%) 174 (60.8%) 112 (39.3%)
Caucasians 154 115 (74.7%) 39 (25.3%) 128 (83.1%) 26 (16.9%)
Hispanics 61 39 (63.9%) 22 (36.1%) 51 (83.6%) 10 (16.4%)
Asians 8 3 (37.5%) 5 (62.5%) 7 (87.5%) 1 (12.5%)
509 509
Values are shown in actual numbers and percentiles (within parenthesis).
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2¼16, d.f.¼1, Po0.001). Separate analysis of
ethnic subsamples revealed, however, that the genotype
effect remains signiﬁcant only in the African-American sub-
sample (w
2¼5.6, d.f.¼1, P¼0.002), and does not reach a
signiﬁcance level in the non-African subsample (w
2¼0.7,
d.f.¼1, P¼0.4).
PER2 allele frequency in different populations is likely
driven by geography. To explain the high divergence in
VNTR-based allele frequencies between the populations in
our sample, we explored the possibility that it might be due
to geography-driven selection. Our inspection of the 100kb
genomic locus encompassing the PER2 revealed that the
highest FST score (FST is commonly used as an estimate
to measure the degree of genetic differentiation among
populations
47) is in the vicinity of intron 3 VNTR (Figure 3).
Also, we noted an abrupt change in population hetero-
zygosity that coincided with the VNTR region (circled).
The degree of population differentiation can be inferred
from a set of population-speciﬁc SNPs classiﬁed by their
physicallocationandfunctionalimpact.Undertheassumption
of neutrality, the degrees of differentiation should be the
same; any deviation from this expectation could be attributed
to selection.
48 Indeed, the variants leading to amino-acid
changes (non-synonymous mutations) are over-represented
among SNPs showing high levels of FST; hence, an excess
of non-synonymous SNPs in one population compared with
the other points out to population-speciﬁc action of natural
selection. Comparison of the population-speciﬁc SNPs
in the PER2 locus (YRI vs CEU) showed an excess of
non-synonymous SNPs (3 vs none) in CEU (Supplementary
Table 1). This ﬁnding is quite unusual, given that the African
populations show a higher level of genetic and nucleotide
diversity than the European population.
49,50
Taken together, these results indicate that the PER2 locus
is under selection pressure that can act discriminately on
some populations and not on the others; hence, pronounced
differences inPER2 allele frequenciesamong populations are
rather expected.
PER2 genotype effect on striatal DRD2 binding
potential. Finally, we assessed an effect of the PER2
VNTR polymorphism on brain endophenotype, using the
baseline measures (non-stimulated) of striatal D2R availability
Table 2 PER2 genotype frequencies in subpopulations
Genotype
4R/4R 4R/3R 3R/3R 4R/2R 3R/2R 2R/2R
African Americans (N¼286) 148 (51.1%) 85 (30.1%) 20 (7.1%) 22 (7.8%) 5 (1.8%) 6 (2.1%)
Non-Africans (N¼223) 197 (88.2%) 20 (8.7%) 3 (1.3%) 3 (1.3%) 0 1 (0.4%)
Abbreviation: PER2, Period 2.
Actual counts of genotype in subpopulations are shown along with percentiles (within parenthesis).
Table 3 HWE equilibrium testing
Genotype Sample African Americans Non-Africans
Obs Exp Obs Exp Obs Exp
(a) Multi-allelic model
4R/4R 346 331 144 138 202 199
4R/3R 105 125 85 91 20 24
3R/3R 23 12 20 15 3 1
4R/2R 25 35 22 27 3 5
3R/2R 5 7 5 9 0 0
2R/2R 7 1 6 1 1 0
w
2¼56.5 w
2¼21.1 w
2¼43.3
(b) Bi-allelic model
4R/4R 346 334.05 144 138.75 202 199.75
4R/3R 105 126.9 85 93.5 20 24.5
3R/3R 23 12.05 20 15.75 3 0.75
w
2¼14.08 w
2¼2.05 w
2¼7.58
Abbreviations: Exp, expected; HWE, Hardy–Weinberg equilibrium; Obs,
observed.
HWE was calculated using popgen genetic applet (a, multiallelic markers) and
OEGE software (b, bi-allelic markers).
Table 4 PER2 genotypes distribution in healthy controls and cocaine abusers
Genotype Total
4R/4R 4R/3R 3R/3R Rare
African Americans
Healthy controls 100 41 13 20 174
Cocaine abusers 48 44 7 13 112
Count 148 85 20 33 286
Non-Africans
Healthy controls 164 19 1 4 188
Cocaine abusers 36 1 2 0 39
Count 200 20 3 4 227
Abbreviation: PER2, Period 2.
Figure 2 PER2 (Period 2) genotype frequencies in controls and cocaine
addicts. PER2 genotype distribution proﬁles (four-genotype classiﬁcation) in the
groups of healthy control and cocaine abusers of African Americans and non-
Africans (values are shown in percentiles).
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11C]raclopride,
as a proxy for brain D2R phenotype (for simplicity, herein
we refer to it as D2R availability). For statistical reasons
(high prevalence of the 4R/4R genotype in non-Africans
diminished the power to detect an association), we included
in this analysis only African-Americans individuals. The brain
imaging data were available for 52 subjects (43 males and
9 females; age: 20–51 (mean: 35±8.9) years). The analysis
of covariance revealed that the effect of the PER2 genotype,
corrected for age, on D2R binding was signiﬁcant in all
striatal regions (Table 5).
Comparison of the genotype groups (four genotype
classiﬁcation) revealed that the 3R/4R heterozygotes’ and
carriers’ rare allele had lower D2R binding across the brain
regions relative to either 4R or 3R homozygotes (Figure 4a).
Representative PET scans of male carriers of 4R/4R and
4R/3R genotypes that participated in the same study are
shown in Figure 4b.
Figure 3 The PER2 (Period 2) region in the Human Genome Diversity Panel (HGDP) Browser. The red and green arrows point to the single-nucleotide polymorphisms
(SNPs) in the vicinity of the intron 3 variable number tandem repeat (VNTR). The blue arrow indicates a spike in FST that coincides with the intron 3 VNTR. Note an abrupt
change in population heterozygosity coinciding with the VNTR region (circled).
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The aim of this study was to interrogate the genomic region of
the human PER2 gene for polymorphic repeats and to
investigate the phenotypic effects of its putative variations
on D2R expression and its association with cocaine addiction.
We discovered a new VNTR polymorphism in intron 3 of the
PER2 gene and found preliminary evidence that this variation
is associated with striatal D2R availability, that is, hetero-
zygous carriers of the shorter, 3R allele, or carriers of rare
alleles had lower D2R availability in the striatum compared
with 4R homozygotes. Comparison of the PER2 allele and
genotypefrequenciesinhealthycontrolsandcocaineabusers
revealed signiﬁcant differences in their patterns, where the
shorter alleles (3R and 2R) were enriched in the group of
cocaine abusers. These two ﬁndings are in line with the
consistent ﬁnding of reduced striatal DRD2 availability in drug
addiction.
3
Observed differences between the populations in PER2
genotype by disease interactions suggest that genetic model
of this polymorphism can be population-speciﬁc. It seems that
effect of the 3R allele in different populations is opposing, so
that African-American 3R/4R heterozygotes have higher risk
for cocaine abuse, whereas in non-Africans the same allele is
over-represented among healthy controls (Figure 2).
To our knowledge, this is the ﬁrst report of an association
between a polymorphism in a circadian gene PER2 (VNTR in
intron 3) and striatal D2R availability in the human brain and
with cocaine addiction. Our ﬁndings are consistent with those
from prior preclinical studies,
24,51 which showed that PER2
modulates the rewarding responses to cocaine in rodents.
However, they differ from the results of a prior clinical study
36
that failed to detect an association between PER2 polymorph-
isms and drug addiction. This is not a contradiction, however,
as the later study was based on SNPs analysis, whereas our
analysis was focused on a new VNTR polymorphism of the
PER2. Furthermore, Malison and others studied heteroge-
neous population, where African-American individuals were
disproportionally over-represented among cocaine abusers
(46%) and under-represented among healthy controls (12%);
that bias may have limited their ability to detect differences.
Here, we accounted for the effect of ethnicity, and to avoid
such bias, analyzed African-American and non-African
populations separately.
Ourﬁndingsprovidenew insightintoa mechanismbywhich
drug-induced disruptions in DA signaling and related changes
in the pattern of clock genes expression might lead to the
development of pathological motivational states such as drug
addiction. New evidence obtained in human populations
advances our current understanding of counter-regulation of
Table 5 Striatal D2R binding in PER2 genotype groups
PER2 genotype F (d.f.) P-value Nonicept Observed power
4R/4R 4R/3R 3R/3R Rare
Caudate 2.7±0.06 2.54±0.06 2.76±0.17 2.14±0.2 (7,44)¼9.18 o0.001 64.3 1
30 15 3 4
Putamen 3.31±0.07 3.08±0.1 3.46±0.22 2.66±0.25 (7,44)¼8.46 o0.001 59.4 1
30 15 3 4
Ventral striatum 2.91±0.09 2.55±0.13 3.02±0.25 2.31±0.29 (7,36)¼4.13 0.002 28.9 0.97
24 13 3 4
Abbreviations: ANCOVA, analysis of covariance; D2R, dopamine D2 receptor; d.f., degrees of freedom; PER2, Period 2.
Values of DRD2 binding in striatal regions by PER2 genotype groups are shown as model adjusted means±s.e. based on the non-transformed DRD2 binding data.
F-value, P-value (signiﬁcance) and observed power (computed using a¼0.05) values are from ANCOVA. Z is a nonicept parameter.
4R/3R
4R/4R
Figure 4 Effect of the PER2 (Period 2) genotypes on striatalD2 receptor (D2R)
binding. (a) The baseline (non-stimulated) measures of striatal D2R availability in
PER2 genotype groups in three striatal regions. Y axis shows non-displaceable
binding potential BP(ND) for [
11C]raclopride. Bars correspond to mean D2R
availability and standard errors of means in PER2 genotype groups in caudate,
putamenandventralstriatum.(b)RepresentativePETscansofthecarriersofPER2
4R/4R and 4R/3R genotypes. Normalized to the SPM template parametric images
of the [
11C]raclopride PET scans. Transaxial planes at the level of the striatum of
individual with 4R/3R genotype (upper panel) and individual with 4R/4R genotype
(bottom panel). Rainbow color scale indicates D2R availability: red shows region
withthehighestandbluewith thelowestreceptorlevels.Notemorered color onthe
planes 3, 4 and 5 of the right panel comparing with the left one, corroborating the
differences in the striatal binding between the genotype groups (Table 4 and
Figure 3).
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based on the investigation of rodents.
24,52,53 Our results can
alsobeinterpretedina contextofpathogenicity ofParkinson’s
disease. In patients with Parkinson’s disease, severe DA
depletion in the striatum
54 was observed in association with
dysregulation of clock genes expression and disruptions of
daily behavioral and physiological rhythms.
55,56
An earlier study by Cruciani et al.
31 reported a sign of
population-speciﬁc selection acting on the PER2 gene that
they detected by analysis of a set of SNPs. Our ﬁndings are
alsoconsistentwithpopulation-speciﬁcpositiveselectionand,
using a new multi-allelic genetic marker, allowed us to detect
statistically signiﬁcant differences in frequency of PER2
alleles and heterozygosity between populations. We noted
hAT-Charlie family DNA retrotransposon (MER20) residing
immediately upstream of the intron 3 VNTR. Recent theore-
tical and experimental studies have characterized transpo-
sable elements as potentially advantageous generators of
variations, which enable the action of natural selection
(reviewed in ref. 57); thus, the MER20 Eutherian-speciﬁc
sequence elements play a central role in rewiring the gene-
regulatory landscape.
58 In light of such evidence and
considering that unusual genotype patterns, homozygosity
and extreme values of FST are indicative of recent adapta-
tion,
59 our results support the action of positive selection on
the human PER2 gene.
This study has several aims and implements different
analytical tools and modalities. We predicted a new poly-
morphism in the PER2 gene and validated it; assessed PER2
allele distribution across ethnic groups corroborating prior
evidence for geography-driven positive selection; determined
differences in genotype patterns between healthy controls
and cocaine users; and ﬁnally, tested a genotype effect on the
levels of striatal D2R availability—a hallmark for addiction
vulnerability. This approach is different from traditionally more
focused studies, but we believe that our characterization of a
new polymorphism is comprehensive and informative. More-
over, previous preclinical data obtained on animal models are
consistent with our ﬁndings, supporting their reliability.
Study limitations
We want to emphasize that our analysis was not aimed to
establish causative relationships between the PER2 and the
D2R, as this would require a different experimental design.
Our population sample is ethnically heterogeneous, rather
than include carefully matched cases and controls, it
comprises participants from different brain imaging studies
performed in our laboratory; it does, however, adequately
represent the diverse population of Long Island, NY, USA.
Because of the relatively small sample size of our imaging
study (as is the case for most imaging genetic studies), we
consider our ﬁnding of an association between variations in
the PER2 gene and brain D2R availability as preliminary and
in need of replication.
We did not include in our analysis traditional markers for the
PER2 locus, as a prior study showed lack of an association
with cocaine addiction.
36
And lastly, considering that D2R availability is inﬂuenced by
environmental exposuresincluding drugs,
60 we didnot expect
that the link between striatal D2R availability and cocaine
addiction could be fully explained by PER2 genotype.
In summary, here we identiﬁed a new VNTR polymorphism
in the PER2 gene (third intron) and showed that the PER2
varianceshavedifferentprevalenceacrossethnicgroups.We
detected a link between the polymorphism and D2R brain
levels and signiﬁcant differences in VNTR allele frequencies
between CA and HC that, in combination, point out that this
genetic variation can contribute to vulnerability for cocaine
addiction and, perhaps, other disorders associated with low
striatalD2Rlevels.Theseﬁndingsbroadenourunderstanding
of the complex networks that regulate brain dopaminergic
transmission, by considering counter-regulation between the
circadian clock and D2R-mediated dopamine signaling.
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